Watchlist Price Alert

Tevogen Bio Inc. (TVGN)

NASDAQ: TVGN · Real-Time Price · USD

1.23

-0.01 (-0.81%)

At close: Jun 16, 2025, 9:48 AM

Tevogen Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Net Income	-10.37M	-9.44M	-5.91M	-9.66M	10.51M	-828.92K	-3.9M	-22.18M	-30.76M	2.61M	1.61M	207K	-25.99K	-17.33K
Depreciation & Amortization	105.4K	103.55K	218.93K	-17.2K	98.3K	259.15K	198.02K	-11.74K	91.21K	196.06K	2.1K	n/a	n/a	n/a
Stock-Based Compensation	7.29M	7.96M	3.33M	3.14M	26.33M	n/a	n/a	n/a	n/a	720.82K	1.26M	n/a	n/a	n/a
Other Working Capital	n/a	1.35M	-320.71K	-80.03K	-1.18M	-187.57K	91.39K	-80.54K	142.39K	160.25K	83.82K	242.31K	80.22K	-571.78K
Other Non-Cash Items	n/a	-2.38M	-331.53K	3.64M	-40.38M	40.05K	1.48M	20.1M	28.43M	-2.87M	-1.88M	-435.96K	-346.52K	-201.61K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	710.77K	-1.15M	-80.03K	517.84K	-46.2K	431.38K	-125.87K	55.8K	198.93K	156.23K	212.69K	169.84K	-533.33K
Operating Cash Flow	-3.31M	-3.05M	-3.8M	-2.98M	-2.16M	-693.71K	-1.8M	-2.22M	-2.18M	-13.86K	-42.6K	-45.9K	-113.03K	-713.83K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-133K	-165.39K	-126.64K	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-67.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-351.9M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	9.71M	n/a	n/a	333.27M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	9.65M	n/a	n/a	-133K	-165.39K	-126.64K	n/a	n/a	-351.9M
Debt Repayment	n/a	n/a	1M	n/a	n/a	350K	1.15M	901K	2.5M	2.5M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-333.6M	333.6M	n/a	n/a	-9.71M	-333.27M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4M	11M	1M	2.8M	229.33K	72.5K	-200K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	4M	2M	5M	2.8M	2.43M	-9.29M	950K	901K	2.5M	2.5M	n/a	n/a	n/a	352.96M
Net Cash Flow	691.94K	-1.05M	1.2M	-182.51K	265.5K	-338.71K	-849.99K	-2.22M	189.87K	-13.86K	-42.6K	-45.9K	-113.03K	344.58K
Free Cash Flow	-3.31M	-3.05M	-3.8M	-2.98M	-2.16M	-693.71K	-1.8M	-2.22M	-2.31M	-179.25K	-169.24K	-45.9K	-113.03K	-713.83K